D. Novotný

发表

Endothelial haemostatic markers in members of families with familial combined hyperlipidemia.

D. Karásek, M. Halenka, H. Vaverkova, 2009, Thrombosis research.

Long-term Olfactory Functions in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment

J. Lehrner, E. Stögmann, D. Novotný, 2022, Chemosensory Perception.

IL28B genotyping and treatment of HCV infected subjects

J. Bednáriková, D. Novotný, K. Aiglova, 2014 .

Total adiponectin levels in dyslipidemic individuals: relationship to metabolic parameters and intima-media thickness.

D. Karásek, M. Halenka, Z. Fryšák, 2011, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

Adiponectin: A Perspective Adipose Tissue Marker with Antiinflammatory and Antiaterogenic Potencial

D. Karásek, H. Vaverkova, D. Novotný, 2012 .

Evaluation of total adiponectin, adipocyte fatty acid binding protein and fibroblast growth factor 21 levels in individuals with metabolic syndrome.

D. Karásek, H. Vaverkova, J. Orság, 2014, Physiological research.

Impaired triglyceride tolerance in hemodialysis patients with different apolipoprotein E (apo E) isoforms.

J. Zahálková, H. Vaverkova, D. Novotný, 2002, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

Fibroblast Growth Factor 21 and Endothelial/Hemostatic Markers in Dyslipidemic Subjects

Vaverková, D. Novotný, 2016 .

Correlation of lipid parameters and markers of insulin resistance: does smoking make a difference?

K. Langová, D. Karásek, L. Cibičková, 2015, Physiological research.

Soluble intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 in asymptomatic dyslipidemic subjects.

D. Karásek, M. Halenka, Z. Fryšák, 2011, International angiology : a journal of the International Union of Angiology.

PO15-407 UNEXPECTEDLY POSITIVE INDEPENDENT ASSOCIATION OF ADIPONECTIN WITH SOLUBLE VASCULAR CELL ADHESION MOLECULE-1 - PROTECTIVE OR HARMFUL?

D. Karásek, M. Halenka, H. Vaverkova, 2007 .

Long-term Olfactory Functions in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment

J. Lehrner, E. Stögmann, D. Novotný, 2022, Chemosensory Perception.

Paraoxonase 2 Cys311Ser polymorphism and its association with the systolic blood pressure values in asymptomatic dyslipidemic individuals: a pilot study

D. Karásek, H. Vaverkova, V. Kubícková, 2015 .

The influence of apolipoprotein A5 T-1131C and apolipoprotein E common genetic variants on the levels of hemostatic markers in dyslipidemic patients.

D. Karásek, H. Vaverkova, L. Slavík, 2014, Clinica chimica acta; international journal of clinical chemistry.

Genetic variants of apolipoprotein A5 T-1131C and apolipoprotein E common polymorphisms and their relationship to features of metabolic syndrome in adult dyslipidemic patients.

D. Karásek, H. Vaverkova, D. Novotný, 2014, Clinical biochemistry.

Total and High Molecular Weight Adiponectin Levels and Prediction of Cardiovascular Risk in Diabetic Patients

V. Janout, D. Pastucha, D. Horáková, 2015, International journal of endocrinology.

Total Adiponectin, Adipocyte Fatty Acid Binding Protein, Fibroblast Growth Factor 21 and Proinflammatory Marker Levels During the Early Stage of Acute Pancreatitis--A Pilot Study.

D. Novotný, P. Malina, Petra Krumpholcová, 2015, Clinical laboratory.

Prothrombotic markers in asymptomatic dyslipidemic subjects

D. Karásek, M. Halenka, Z. Fryšák, 2010, Journal of Thrombosis and Thrombolysis.

Comparison of apolipoprotein B and plasma lipids as targets for lipid lowering treatment.

J. Frohlich, H. Vaverkova, D. Novotný, 2005, Clinical biochemistry.

Detection of early atherosclerosis using the ultrasound parameter of the intima-media thickness of the common carotid artery in families with familial combined hyperlipidemia.

M. Hutyra, M. Krskova, D. Karásek, 2004, International angiology : a journal of the International Union of Angiology.

Benefits of three-month continuous glucose monitoring for persons with diabetes using insulin pumps and sensors.

V. Matušková, J. Zapletalová, R. Chlup, 2009, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

Prehypertension in dyslipidemic individuals; relationship to metabolic parameters and intima-media thickness.

D. Karásek, M. Halenka, Z. Fryšák, 2013, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

Intima media thickness measurement as a marker of subclinical atherosclerosis in SLE patient.

P. Horák, K. Langová, J. Zadražil, 2013, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

Apolipoprotein B versus LDL-cholesterol: Association with other risk factors for atherosclerosis.

J. Frohlich, D. Karásek, M. Halenka, 2009, Clinical biochemistry.

Omega-3 fatty acid supplementation candidates can be selected using fatty acid profiling

M. Holčapek, J. Vostálová, M. Táborský, 2015 .

Omega-3 fatty acid supplementation candidates can be selected using fatty acid pro fi ling

M. Holčapek, J. Vostálová, M. Táborský, 2015 .

Relationship between serum adipocyte fatty acid-binding protein and endothelial/hemostatic markers in dyslipidemic subjects.

D. Karásek, M. Halenka, Z. Fryšák, 2012, Neuro endocrinology letters.

Soluble cell adhesion molecules s-VCAM-1 and s-ICAM-1 in subjects with familial combined hyperlipidemia.

M. Budíková, D. Karásek, M. Halenka, 2005, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

Positive association of adiponectin with soluble thrombomodulin, von Willebrand factor and soluble VCAM-1 in dyslipidemic subjects.

J. Frohlich, D. Karásek, M. Halenka, 2013, Clinical biochemistry.

[Lipoprotein (a): a genetic risk factor for early ischemic cerebrovascular stroke].

I. Vlachová, H. Vaverkova, D. Novotný, 1993, Vnitrni lekarstvi.

Hypertriglyceridemic waist - a simple clinical tool to detect cardiometabolic risk: comparison with harmonized definition of metabolic syndrome.

D. Karásek, M. Halenka, H. Vaverkova, 2015, Physiological research.

Positive association of adiponectin with soluble vascular cell adhesion molecule sVCAM-1 levels in patients with vascular disease or dyslipidemia.

J. Frohlich, D. Karásek, M. Halenka, 2008, Atherosclerosis.

Total and High Molecular Weight Adiponectin Levels and Prediction of Cardiovascular Risk in Diabetic Patients.

V. Janout, D. Pastucha, D. Horáková, 2015, International Journal of Endocrinology.

Predictive Value of Ultrasensitive C-Reactive Protein in Ischemic Cerebrovascular Accident and Its Relation to Atherosclerosis of Carotid Arteries

P. Kaňovský, M. Budíková, R. Herzig, 2019 .